Tricuspid stenosis epidemiology and demographics: Difference between revisions
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Tricuspid stenosis}} | {{Tricuspid stenosis}} | ||
{{CMG}} | |||
==Overview== | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Revision as of 19:17, 2 January 2015
|
Tricuspid stenosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tricuspid stenosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Tricuspid stenosis epidemiology and demographics |
|
Tricuspid stenosis epidemiology and demographics in the news |
|
Risk calculators and risk factors for Tricuspid stenosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
Prevalence
TS is the least common valvular disease. Among patient with rheumatic heart disease, it was reported that approximately 8% develop isolated TS, while up to 50% develop tricuspid regurgitation and TS.[1]
The prevalence of TS in developed countries is low due to the low prevalence of rheumatic heart disease, the most common cause of TS. The prevalence of TS is higher in developing countries due tot the higher prevalence of rheumatic heart disease.
Mortality/Morbidity
- Mortality is dependent upon the precipitating cause
- Mortality rate is 5%
Race
There does not seem to be any racial predisposition
Sex
- Observed more in women
- Congenital form is slightly more prevalent in men
Age
- Congenital form accounts for 0.3% of all congenital heart diseases
- Due to secondary causes, in the older population, frequency is between 0.3 - 3.2%
References
- ↑ Goswami KC, Rao MB, Dev V, Shrivastava S (1999). "Juvenile tricuspid stenosis and rheumatic tricuspid valve disease: an echocardiographic study". Int J Cardiol. 72 (1): 83–6. PMID 10636636.